Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 03 Sept 2026 for Kiniksa Pharmaceuticals International, plc. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
John F. Paolini: trading record in brief
All filings by John F. Paolini on record concern Kiniksa Pharmaceuticals International, plc, in the capacity of senior executive. We count 44 filings; the first trade dates from 7 October 2019 and the latest from 1 September 2026.
Sales make up the whole of the open-market record (5 sales, €743k). The rest of the record consists of 3 share grants and 36 option exercises.
The latest filing, published on 3 September 2026, reports an option exercise in Kiniksa Pharmaceuticals International, plc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John F. Paolini
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
1,750 sharesClass A Ordinary ShareSEC:0001741533-26-000010:2
2,457 sharesClass A Ordinary ShareSEC:0001741533-26-000010:3
4,029 shares@ US$79.282.15% mcap26.2% of flowClass A Ordinary ShareSEC:0001741533-26-000010:4
2,497 sharesClass A Ordinary ShareSEC:0001741533-26-000010:0
1,624 sharesClass A Ordinary ShareSEC:0001741533-26-000010:1
1,208 shares@ US$48.9456.9% of flowClass A Ordinary ShareSEC:0001741533-26-000006:1
2,497 sharesClass A Ordinary ShareSEC:0001741533-26-000006:0
2,821 shares@ US$48.1356.8% of flowClass A Ordinary ShareSEC:0001741533-26-000004:1
5,831 sharesClass A Ordinary ShareSEC:0001741533-26-000004:0
40,000 shares@ US$10.3645.5% of flowClass A Ordinary ShareSEC:0001741533-26-000002:0
36,542 shares@ US$3.8028.5% of flowClass A Ordinary ShareSEC:0001741533-25-000003:0
1,750 sharesClass A Ordinary ShareSEC:0001415889-25-023555:0
29,325 shares@ US$3.8031.7% of flowClass A Ordinary ShareSEC:0001415889-25-021346:0
200 shares@ US$3.801.8% of flowClass A Ordinary ShareSEC:0001415889-25-012541:0
2,498 sharesClass A Ordinary ShareSEC:0001415889-25-010480:0
1,624 sharesClass A Ordinary ShareSEC:0001415889-25-010007:0
1,725 sharesClass A Ordinary ShareSEC:0001415889-25-008612:0
4,121 sharesClass A Ordinary ShareSEC:0001415889-24-022856:0
22,000 shares@ US$1.8698.2% of flowClass A Ordinary ShareSEC:0001415889-24-020104:0
2,497 sharesClass A Common ShareSEC:0001415889-24-010511:0
1,624 sharesClass A Common ShareSEC:0001415889-24-010077:0
18,844 shares@ US$1.8616.1% of flowClass A Common ShareSEC:0001415889-24-006674:0
10,156 shares@ US$1.868.7% of flowClass A Common ShareSEC:0001415889-24-005883:0
28,600 shares@ US$1.8624.6% of flowClass A Common ShareSEC:0001415889-23-016183:0
2,498 sharesClass A Common ShareSEC:0001415889-23-013038:0
25 of 32 declarations
